Clinical outcomes of laparo-endoscopic single-site surgery radical nephrectomy.

Jens-Uwe Stolzenburg, Panagiotis Kallidonis, Narasimhan Ragavan, Anja Dietel, Minh Do, Phuc Ho Thi, Holger Till, Evangelos N Liatsikos

Journal: World journal of urology 2013;30(5):589-96

PMID: 21960202

Abstract

INTRODUCTION

The conventional laparoscopic surgery is now paving way to the new technologies including robotic and laparoscopic single-site surgery (LESS). We present our updated experience on LESS radical nephrectomy (LESS-RN).

PATIENTS AND METHODS

The data from patients undergoing LESS-RN in our two institutions were reviewed along with various clinical and pathological parameters.

RESULTS

Between 2008 and 2011, 42 LESS-RN were performed (right = 22, left = 20) with mean (range) age and BMI of 63.7 (33-86) years and 25.1 (18-38.6) kg/m(2), respectively. In addition to the instruments in the single port, one extra 3-mm needlescopic instrument was required in 19 patients (right = 17, left = 2). In three patients, two additional 5-mm trocars and instruments were required. None required open conversion. The recorded adverse events include one bowel injury (intraoperative closure without the need for stoma), one postoperative bleeding requiring blood transfusion, one prolonged ileus, and one deep venous thrombosis. The resected specimens revealed pT1a (n = 3), pT1b (n = 33), pT2a (n = 4), and pT3b (n = 2) tumors. The finding of pT3b was incidental rather than planned procedure. None of the patients had positive margins.

CONCLUSION

LESS-RN has proven to be feasible and safe. Beyond cosmesis, further advantages of this approach need to be addressed by randomized trials.

Address: Department of Urology, University of Leipzig, Leipzig, Germany.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.